These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 4074426

  • 21. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T, Kobayashi K, Katayama Y, Takada T, Matsuyama T.
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
    Hongou K, Miyamae T, Hashizume H, Oshima K, Ogawa T, Hongou T, Morikawa T, Hagiwara M.
    Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH, Suh DY, Yang HO, Park YH, Kang YH, Kim YC.
    Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased external carotid artery blood flow in headache patients induced by cilostazol. Preliminary communication.
    Yamashita K, Kobayashi S, Okada K, Tsunematsu T.
    Arzneimittelforschung; 1990 May; 40(5):587-8. PubMed ID: 2383301
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interaction potential and tolerability of the coadministration of cilostazol and aspirin.
    Mallikaarjun S, Forbes WP, Bramer SL.
    Clin Pharmacokinet; 1999 May; 37 Suppl 2():87-93. PubMed ID: 10702891
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antiplatelet and antithrombotic activity of cilostazol is potentiated by dipyridamole in rabbits and dissociated from bleeding time prolongation.
    Li H, Cone J, Fong M, Kambayashi J, Yoshitake M, Liu Y.
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):41-8. PubMed ID: 15883755
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K, Cissé-Thiam M, Drouet L.
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.